Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
29.50
-0.50 (-1.67%)
At close: Mar 9, 2026, 4:00 PM EDT
28.91
-0.59 (-2.00%)
After-hours: Mar 9, 2026, 7:41 PM EDT
Sensei Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 37 | 12 | 17 | 46 | 177 | - | |
| Market Cap Growth | 217.42% | -28.74% | -62.21% | -74.21% | - | - | |
| Enterprise Value | 13 | -30 | -48 | -62 | 22 | - | |
| Last Close Price | 30.00 | 9.80 | 13.84 | 29.80 | 116.00 | - | |
| PB Ratio | 1.64 | 0.32 | 0.27 | 0.44 | 1.21 | - | |
| P/TBV Ratio | 1.59 | 0.32 | 0.27 | 0.44 | 1.21 | - | |
| Debt / Equity Ratio | 0.09 | 0.10 | 0.10 | 0.08 | 0.02 | 0.04 | |
| Net Debt / Equity Ratio | -1.00 | -0.98 | -0.92 | -0.96 | -0.99 | -1.00 | |
| Net Debt / EBITDA Ratio | 0.98 | 1.26 | 1.67 | 2.03 | 3.95 | 0.86 | |
| Net Debt / FCF Ratio | 1.03 | 1.51 | 1.85 | 2.52 | 4.50 | 0.84 | |
| Quick Ratio | 5.65 | 7.59 | 11.65 | 11.82 | 30.20 | 3.44 | |
| Current Ratio | 5.81 | 7.70 | 11.92 | 11.98 | 30.38 | 4.16 | |
| Return on Equity (ROE) | -70.18% | -58.40% | -40.52% | -38.88% | -45.31% | - | |
| Return on Assets (ROA) | -37.04% | -32.32% | -24.04% | -23.10% | -26.83% | -103.30% | |
| Return on Capital Employed (ROCE) | -103.50% | -77.60% | -53.90% | -45.90% | -25.30% | -112.70% | |
| Earnings Yield | -66.19% | -244.65% | -197.14% | -106.15% | -20.73% | - | |
| FCF Yield | -61.41% | -201.32% | -186.17% | -85.96% | -18.19% | - | |
| Buyback Yield / Dilution | -0.52% | 10.14% | 8.96% | -10.80% | -1618.88% | -338.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.